| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Jun―18 |
The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus |
Cyril Debuysschere, Magloire Pandoua Nekoua, Enagnon Kazali Alidjinou, Didier Hober |
| 2 |
[GO] |
2024―Feb―12 |
Thyroid dysfunction in COVID-19 |
David Tak Wai Lui, Chi Ho Lee, Yu Cho Woo, Ivan Fan Ngai Hung, Karen Siu Ling Lam |
| 3 |
[GO] |
2022―Dez―09 |
Sex hormones in SARS-CoV-2 susceptibility: key players or confounders? |
Nicola Lott, Caroline E. Gebhard, Susan Bengs, Ahmed Haider, Gabriela M. Kuster, Vera Regitz-Zagrosek, Catherine Gebhard |
| 4 |
[GO] |
2022―Nov―02 |
SARS-CoV-2 fires up inflammation in adipose tissue |
Norbert Stefan |
| 5 |
[GO] |
2022―Mai―30 |
Is there a role for the adrenal glands in long COVID? |
Waldemar Kanczkowski, Felix Beuschlein, Stefan R. Bornstein |
| 6 |
[GO] |
2021―Dez―06 |
Metabolic disorders, COVID-19 and vaccine-breakthrough infections |
Norbert Stefan |
| 7 |
[GO] |
2021―Jun―14 |
How COVID-19 disrupts glycometabolic control |
Shimona Starling |
| 8 |
[GO] |
2021―Jun―10 |
Severe COVID-19 outcomes - the role of physical activity |
Jean-Pierre Després |
| 9 |
[GO] |
2021―Jun―02 |
The emerging osteo-metabolic phenotype of COVID-19: clinical and pathophysiological aspects |
Luigi di Filippo, Stefano Frara, Andrea Giustina |
| 10 |
[GO] |
2021―Mai―12 |
Glucose-lowering treatments and COVID-19 mortality in T2DM |
Samy Hadjadj, Matthieu Wargny |
| 11 |
[GO] |
2021―Apr―19 |
Long COVID - metabolic risk factors and novel therapeutic management |
Kamlesh Khunti, Melanie J. Davies, Mikhail N. Kosiborod, Michael A. Nauck |
| 12 |
[GO] |
2021―Feb―24 |
Effects of pancreatic SARS-CoV-2 infection identified |
Alan Morris |
| 13 |
[GO] |
2021―Jan―21 |
Global pandemics interconnected - obesity, impaired metabolic health and COVID-19 |
Norbert Stefan, Andreas L. Birkenfeld, Matthias B. Schulze |
| 14 |
[GO] |
2021―Jan―18 |
Reply to: Autonomic dyshomeostasis in patients with diabetes mellitus during COVID-19 |
Soo Lim, Jae Hyun Bae, Hyuk-Sang Kwon, Michael A. Nauck |
| 15 |
[GO] |
2021―Jan―15 |
Autonomic dyshomeostasis in patients with diabetes mellitus during COVID-19 |
Virginia Boccardi |
| 16 |
[GO] |
2020―Nov―25 |
COVID-19 alters thinking and management in metabolic diseases |
Carel W. le Roux |
| 17 |
[GO] |
2020―Nov―13 |
COVID-19 and diabetes mellitus: from pathophysiology to clinical management |
Soo Lim, Jae Hyun Bae, Hyuk-Sang Kwon, Michael A. Nauck |
| 18 |
[GO] |
2020―Sep―14 |
UK policy targeting obesity during a pandemic - the right approach? |
|
| 19 |
[GO] |
2020―Jul―08 |
Will the COVID-19 pandemic worsen the obesity epidemic? |
Christoffer Clemmensen, Michael Bang Petersen, Thorkild I. A. Sørensen |
| 20 |
[GO] |
2020―Jun―11 |
Managing fragility fractures during the COVID-19 pandemic |
Nicola Napoli, Ann L. Elderkin, Douglas P. Kiel, Sundeep Khosla |
| 21 |
[GO] |
2020―Apr―23 |
Obesity and impaired metabolic health in patients with COVID-19 |
Norbert Stefan, Andreas L. Birkenfeld, Matthias B. Schulze, David S. Ludwig |
| 22 |
[GO] |
2020―Apr―02 |
Endocrine and metabolic link to coronavirus infection |
Stefan R. Bornstein, Rinkoo Dalan, David Hopkins, Geltrude Mingrone, Bernhard O. Boehm |
